I3 Nirf

1 known investors

i3 develops intravascular imaging technology that combines ultrasound (IVUS) with near-infrared fluorescence (NIRF) for physicians performing percutaneous coronary intervention procedures. The technology provides real-time visualization of vascular anatomy and tissue characteristics to improve guidewire placement and stent positioning during coronary angioplasty.

Medical Devices